Join our upcoming webinar to see how seqWell’s plexWell technology has benefited Addgene and the fight against COVID19. Click HERE to register today!
The economics of using sequencing in place of microarrays is further increased by plexWell’s ability to create balanced pools of libraries that efficiently multiplex as many genomic samples as possible on high-output sequencing runs. SeqWell has demonstrated the use of plexWell™ for routine low-pass human WGS applications, where we show robust and scalable genotype imputation accuracy in combination with Gencove’s imputation SaaS.
Gencove’s imputation SaaS in combination with seqWell’s low pass library preparation kit outperforms genotyping arrays.